- Home
- PZZA vs DVAX Comparison
PZZA vs DVAX Comparison
Compare PZZA & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZZA
- DVAX
- Stock Information
- Founded
- PZZA 1984
- DVAX 1996
- Country
- PZZA United States
- DVAX United States
- Employees
- PZZA 11400
- DVAX N/A
- Industry
- PZZA Restaurants
- DVAX Biotechnology: Pharmaceutical Preparations
- Sector
- PZZA Consumer Discretionary
- DVAX Health Care
- Exchange
- PZZA Nasdaq
- DVAX Nasdaq
- Market Cap
- PZZA 1.4B
- DVAX 1.3B
- IPO Year
- PZZA 1993
- DVAX 2004
- Fundamental
- Price
- PZZA $40.27
- DVAX $11.23
- Analyst Decision
- PZZA Buy
- DVAX Buy
- Analyst Count
- PZZA 12
- DVAX 4
- Target Price
- PZZA $51.73
- DVAX $26.25
- AVG Volume (30 Days)
- PZZA 839.7K
- DVAX 1.3M
- Earning Date
- PZZA 08-07-2025
- DVAX 08-07-2025
- Dividend Yield
- PZZA 4.58%
- DVAX N/A
- EPS Growth
- PZZA 4.47
- DVAX N/A
- EPS
- PZZA 2.37
- DVAX N/A
- Revenue
- PZZA $2,063,780,000.00
- DVAX $294,620,000.00
- Revenue This Year
- PZZA $4.35
- DVAX $21.18
- Revenue Next Year
- PZZA $3.30
- DVAX $16.83
- P/E Ratio
- PZZA $16.95
- DVAX N/A
- Revenue Growth
- PZZA N/A
- DVAX 24.76
- 52 Week Low
- PZZA $30.16
- DVAX $9.22
- 52 Week High
- PZZA $60.75
- DVAX $14.63
- Technical
- Relative Strength Index (RSI)
- PZZA 31.27
- DVAX 57.10
- Support Level
- PZZA $41.70
- DVAX $10.67
- Resistance Level
- PZZA $43.49
- DVAX $11.31
- Average True Range (ATR)
- PZZA 1.45
- DVAX 0.29
- MACD
- PZZA -0.46
- DVAX -0.02
- Stochastic Oscillator
- PZZA 8.90
- DVAX 56.47
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.